- Al Gore’s climate-changers at EPA hearings foiled by cool temperatures
- Army’s 3-D printed bombs will create ‘a whole new universe’ of deadly capabilities
- Hamas calls on Hezbollah to join in fight against Israel
- Senators to FIFA, others: Don’t reward Putin with the World Cup in 2018
- U.S. condemns Israeli shelling of shelter in Gaza
- Obamacare shoots premiums up by 88 percent in California
- Chicken pox outbreak puts illegal immigrant facility on lockdown
- Obama to Republicans: ‘Stop just hatin’ all the time’
- U.S. chemical sites vulnerable despite millions spent on security: Congress
- Driverless cars to hit the British streets by 2015
Key dates in history of thalidomide
Question of the Day
BERLIN (AP) - 1946_ Gruenenthal, a German pharmaceutical, is founded in Stolberg.
1954 _ Gruenenthal discovers and patents thalidomide.
1957 _ Thalidomide is first sold as Contergan in Germany. It is mainly prescribed to treat anxiety and morning sickness in pregnant women.
1959 _ Gruenenthal is first warned by a gynecologist that using the drug leads to deformities in babies.
1960 _ U.S. Food and Drug Administration demands a toxicity study for thalidomide to prove it is safe in humans.
1960s _ Thalidomide is marketed in Europe, Australia, Canada and Japan. The drug was never approved in the U.S.
1961 _ Doctors in Germany, Australia and the U.K. notice a significant spike in the number of babies born with missing or shortened limbs. The birth defects are eventually linked to thalidomide and the drug is pulled from the market.
1962 _ U.S. President John F. Kennedy awards FDA official Dr. Frances O. Kelsey the Distinguished Federal Civilian Service Medal for her diligence in blocking the approval of thalidomide.
1968 _ German case launched by lawyers of families affected by thalidomide against Gruenenthal owner Hermann Wirtz and eight employees.
1970 _ Gruenenthal offers to settle the case for 100 million Deutschmark.
1972 _ Creation of foundation for German thalidomide victims. German state adds 100 million Deutschmarks to fund. In 2009, Gruenenthal adds a further (EURO)150 million; fund totals (EURO)150 million.
1998 _ Thalidomide is approved by the FDA for treating a complication of leprosy.
2006 _ Thalidomide is approved for treating multiple myeloma, a bone marrow cancer.
2012 _ Australian thalidomide survivor wins multimillion settlement from British distributor, German maker Gruenenthal refuses to settle.
2012 _ Gruenenthal apologizes to mothers who took the drug and asks for forgiveness.
TWT Video Picks
- Geraldo Rivera: Matt Drudge 'doing his best to stir up a civil war'
- Lois Lerner hated conservatives, new emails show
- Catholic League slams Obama: 'Do Christian lives mean so little to you?'
- HURT: Impeaching Obama is a losing strategy for the GOP
- CARSON: Rudderless U.S. foreign policy
- Patent workers paid to exercise, shop, do chores: report
- Federal judge grants 90-day stay in D.C. gun case
- Fla. mom arrested for allowing 7-year-old son to walk to park alone
- Senate overcomes first filibuster of Obama's border-spending bill
- Obama thanks Muslims for 'building the very fabric of our nation'
Obama's biggest White House 'fails'
Celebrities turned politicians
Athletes turned actors
20 gadgets that changed the world